Tumor-associated antigens T-cell therapy (Cell Medica)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTumor-associated antigens T-cell therapy (Cell Medica)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionN/A
TargetsNot applicable
Therapy Area/IndicationsNasopharyngeal NeoplasmsLymphomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCell Medica Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCell Medica Ltd
Active IndicationsN/A
Inactive IndicationsNasopharyngeal NeoplasmsLymphomaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A